Categories: News

Metavesco Releases White Paper on Tokenizing the OTC in Advance of Crypto Roundtable with SEC

CUMMING, Ga., Aug. 26, 2025 /PRNewswire/ — Metavesco, Inc. (OTC: MVCO), a publicly traded diversified holding company, today announced the release of its white paper, “Tokenizing the OTC: A Vision for Transparency, Liquidity, and Growth.” The publication outlines Metavesco’s strategy for advancing the tokenization of OTC-traded equities to unlock global liquidity and reduce systemic barriers for small public companies.

- Advertisement -

The white paper is available at: https://metavesco.com/metavesco-inc/tokenizing-the-otc-a-vision-for-transparency-liquidity-and-growth/

- Advertisement -

Metavesco’s release comes ahead of the Company’s participation in an upcoming SEC crypto roundtable hosted by Commissioner Hester Peirce on September 4, 2025, at the SEC’s Fort Worth regional office. Commissioner Peirce invited early-stage crypto projects to share ideas and challenges in navigating the U.S. regulatory landscape, and Metavesco responded with its interest in tokenizing OTC securities.

- Advertisement -

“This white paper represents more than just an idea, rather it’s a roadmap for transforming how small-cap companies raise capital and how investors participate in OTC markets,” said Ryan Schadel, CEO of Metavesco. “Tokenization can eliminate toxic financing models, reduce hidden risks, and bring transparency where it has never existed. Our mission is to make the OTC great again by moving it on-chain.”

- Advertisement -

Key highlights from the paper include:

- Advertisement -
  • Unlocking global liquidity through tokenized share trading
  • Delivering on-chain transparency to eliminate naked shorting and hidden dilution
  • Lowering the cost of capital for legitimate small companies
  • Turning the public into the analyst community through open blockchain data

Participation in the SEC’s roundtable underscores Metavesco’s commitment to building in public, engaging directly with regulators, and positioning itself as a leader at the intersection of OTC markets and Web3 innovation.

- Advertisement -

Metavesco expects the SEC to publish the official participant list ahead of the roundtable event.

- Advertisement -

About Metavesco, Inc.

- Advertisement -

Metavesco is a diversified holding company focused on acquiring and managing assets across multiple sectors, including consumer packaged goods and staffing services. The company is dedicated to long-term growth through organic expansion, strategic acquisitions and innovative market solutions.

- Advertisement -

Safe Harbor Statement

- Advertisement -

This press release contains statements that constitute forward-looking statements. These statements appear in a number of places in this press release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; and (iii) growth strategy and operating strategy. The words “may”, “would”, “will”, “expect”, “estimate”, “can”, “believe”, “potential”, and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is included in the Company’s filings on otcmarkets.com.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/metavesco-releases-white-paper-on-tokenizing-the-otc-in-advance-of-crypto-roundtable-with-sec-302539288.html

- Advertisement -

Recent Posts

Calidi Biotherapeutics Provides Required NYSE American Disclosure

May 22, 2026 18:00 ET  | Source: Calidi Biotherapeutics, Inc SAN DIEGO, May 22, 2026…

6 hours ago

GlycoPulse Claims Evaluated: Most Advanced Blood Sugar Support Ingredients for Healthy Glucose Management by Glyco Pulse

Largo, FL, May 22, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by…

6 hours ago

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

– Financing includes leading U.S. biotechnology institutional investors and mutual funds – LOS ANGELES, CA,…

6 hours ago

AutoFlight V5000 Matrix Concludes ‘Heterogeneous Three-Aircraft Formation’ Flight, Officially Kicks Off Airworthiness Certification

KUNSHAN, China, May 24, 2026 /PRNewswire/ -- AutoFlight has successfully completed a demonstration flight of…

7 hours ago

C-Lingo: Transforming Chinese Language Learning in Vietnam with AI

HONG KONG, May 24, 2026 (GLOBE NEWSWIRE) -- As economic and cultural exchanges between Vietnam…

17 hours ago

Crypto News Today: AlphaPepe AI DEX Hits 5,000 Users While Bitcoin Price Prediction Eyes $180,000

MONACO, May 23, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

17 hours ago